Top 10 Liver Transplant Hospitals in the World
Liver transplantation remains one of the most complex and life-saving procedures in modern medicine. It is the definitive treatment for end-stage liver disease, acute liver failure, certain liver cancers, and metabolic disorders when other therapies fail. Globally, tens of thousands of liver transplants are performed each year, with outcomes improving steadily thanks to advances in surgical technique, organ preservation, immunosuppression, and multidisciplinary care. Success depends heavily on center experience (volume), team expertise, infrastructure, living- and deceased-donor programs, and rigorous post-transplant follow-up. One-year patient survival at high-performing centers commonly exceeds 90–95%, with longer-term rates remaining strong when care is optimized.
No single official global ranking exists that combines all metrics uniformly, because data systems, organ allocation rules, and reporting standards differ by country. Evaluations typically weigh transplant volume, risk-adjusted survival rates (from sources such as the U.S. Scientific Registry of Transplant Recipients), cumulative experience, innovation in living-donor and complex cases, research output, and patient outcomes. The following list of leading hospitals draws on recent high-volume data, reported survival rates, and established international reputation. It prioritizes centers with demonstrated excellence rather than a rigid numerical score.
1. Asan Medical Center (Seoul, South Korea)
Asan Medical Center stands out for unmatched cumulative volume and exceptional outcomes. By 2025 it had performed more than 9,000 liver transplants—the highest number reported by any single institution worldwide—including over 7,500 living-donor procedures. One-year survival reaches approximately 98%, with three-year rates around 90% and ten-year rates near 89%, figures that compare favorably with or exceed those of many leading Western centers. The program specializes in complex living-donor techniques (including modified right-lobe grafts and ABO-incompatible transplants) and has pioneered methods that expanded the donor pool. High annual throughput sustains surgical expertise and refined protocols, making Asan a global reference for living-donor liver transplantation.
2. Cleveland Clinic (Cleveland, Ohio, USA)
Cleveland Clinic’s main campus ranked among the highest-volume U.S. centers in recent years, performing 258 liver transplants in 2024 according to claims data analyses. The integrated transplant program benefits from the institution’s overall strength in complex care, advanced imaging, and critical-care resources. Outcomes are strong, supported by experience with both deceased- and living-donor transplants and a focus on high-risk patients. The clinic’s multidisciplinary model and research activity contribute to continuous refinement of techniques and immunosuppression strategies.
3. Mayo Clinic (Rochester, Minnesota; Phoenix, Arizona; Jacksonville, Florida, USA)
Mayo Clinic’s three-site liver transplant program is one of the largest and most experienced in the United States, with a cumulative total exceeding 11,500 transplants since the mid-1980s. The program handles a high annual volume (hundreds across campuses) and is recognized for excellent risk-adjusted outcomes, innovation in extended-criteria donors, multi-organ transplants, and care of complex patients (including those with obesity or bile-duct cancer). Mayo consistently ranks highly in gastroenterology and hepatology assessments and emphasizes seamless pre- and post-transplant coordination.
4. UCLA Medical Center (Los Angeles, California, USA)
UCLA has reported leading volumes in recent U.S. registry periods, with over 1,000 transplants in some multi-year reporting windows and a substantial national share. The program is known for experience with high-acuity cases, living-donor transplantation, and research that has influenced organ-allocation and cancer-related transplant criteria. Strong survival rates and a large clinical infrastructure support its position among the top U.S. centers.
5. Medanta – The Medicity (Gurugram, India)
Medanta houses one of Asia’s largest and most successful living-donor liver transplant programs, with thousands of procedures completed and annual volumes often exceeding several hundred. Success rates are frequently reported around 95%, with particular strength in adult and pediatric living-donor transplants, ABO-incompatible cases, and complex hepato-pancreato-biliary surgery. Led by pioneering teams, the institute combines high volume with dedicated intensive-care resources and has become a major destination for patients from South Asia, the Middle East, and beyond seeking cost-effective, high-quality care.
6. Apollo Hospitals (Multiple locations, especially Chennai and Delhi, India)
Apollo pioneered successful liver transplantation in India and has accumulated thousands of cases (reports cite more than 4,000). The network offers both adult and pediatric programs, living- and deceased-donor options, and multi-organ capability. Success rates commonly exceed 90%, and the hospitals maintain JCI accreditation and international patient services. Apollo’s early milestones and sustained volume have helped establish India as a global leader in living-donor liver transplantation volume.
7. Mount Sinai Hospital (New York, USA)
Mount Sinai ranks among high-volume U.S. centers and is recognized for expertise in complex liver disease, living-donor transplantation, and integrated care for patients with advanced cirrhosis or malignancy. Strong outcomes, research contributions, and a large multidisciplinary team support its standing in national comparisons.
8. Memorial Hospital Group (Istanbul, Turkey – e.g., Şişli and Bahçelievler campuses)
Turkish centers, particularly within the Memorial network, have become prominent for high-volume living-donor programs, success rates often reported in the low-to-mid 90% range, and efficient international-patient pathways. Experienced surgical teams handle both adult and pediatric cases, and the hospitals emphasize modern facilities, multidisciplinary coordination, and competitive pricing relative to Western centers. These attributes make Memorial a frequent choice for medical travelers.
9. UCSF Medical Center (San Francisco, California, USA)
UCSF is a high-volume program with particular strength in living-donor transplants (often ranking near the top in the western United States) and complex or high-risk cases. Cumulative experience exceeds 5,000 transplants. Risk-adjusted survival rates frequently meet or exceed national averages, and the center is noted for research, expanded eligibility criteria, and innovation in organ preservation and patient selection.
10. Liv Hospital / Acıbadem Group centers (Istanbul, Turkey)
These JCI-accredited Turkish institutions maintain active, high-quality liver transplant programs with substantial living-donor experience and reported success rates above 90%. They attract international patients through comprehensive packages, experienced teams, and modern infrastructure. Volume and outcomes place them among the stronger options outside the United States, South Korea, and India.
Key Considerations When Choosing a Center
Volume matters because higher caseloads correlate with refined technique and better complication management, but risk-adjusted survival and program-specific reports (such as those from SRTR in the U.S.) provide essential context. Living-donor expertise is critical in regions with limited deceased-donor supply. Logistics, cost (which can range from roughly $25,000–$50,000 in parts of Asia and Turkey to several hundred thousand dollars in the United States), insurance coverage, travel, language support, and long-term follow-up arrangements also influence decisions. Patients should review the latest center-specific outcome data, discuss individual risk factors with transplant teams, and consider second opinions.
Advances such as machine perfusion for organ preservation, refined immunosuppression, robotic or minimally invasive donor surgery, and better management of metabolic and viral liver diseases continue to improve results across leading centers. Global collaboration and data sharing further raise standards.
Conclusion
The top liver transplant hospitals—led by high-volume powerhouses such as Asan Medical Center, Cleveland Clinic, Mayo Clinic, UCLA, and major Indian and Turkish programs—demonstrate that excellence arises from sustained surgical experience, multidisciplinary integration, rigorous outcome tracking, and a commitment to expanding the donor pool through living donation and technical innovation. Survival rates at these institutions routinely surpass 90% at one year and remain strong over longer horizons, offering renewed quality of life to patients who once faced limited options. While rankings evolve with new data and local organ-donation rates, the centers highlighted here consistently deliver the combination of volume, expertise, and results that define world-class care. Prospective patients and families should use this overview as a starting point, then engage directly with transplant teams to evaluate the best match for individual medical needs, logistics, and preferences. Continued progress in the field promises even better outcomes and broader access in the years ahead.